Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02826161
Title A Study of Napabucasin (BBI-608) Plus Weekly Paclitaxel Versus Weekly Paclitaxel Alone in Patients With Advanced, Previously Treated, Non-Squamous Non-Small Cell Lung Cancer (CanStem43L)
Acronym CanStem43L
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Boston Biomedical, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.